This may account for the dual functions of CARD9 that is a tumor promoter and/or tumor inhibitor (Yang et al., 2007; Yang et al., 2008; Bergmann et al., 2017; Haas et al., 2017). The gene discussed is CARD9; the disease is neoplasm.